June 2026 Merck expanded its specialty chemical and research ingredient portfolio by introducing advanced betulinic acid solutions featuring improved purity, quality standards, and research-grade applications. The company focused on supporting pharmaceutical, biotechnology, and academic research activities involving natural bioactive compounds.
April 2026 Cayman Chemical expanded its bioactive compound portfolio by strengthening its betulinic acid product offerings for scientific research, drug discovery, and biochemical studies. The company focused on providing high-quality analytical and research materials for pharmaceutical applications.
January 2026 Selleck Chemicals expanded its natural compound research portfolio by developing enhanced betulinic acid products designed for oncology research, molecular studies, and therapeutic discovery applications.
October 2025 TCI Chemicals expanded its specialty reagent portfolio by introducing improved betulinic acid formulations with enhanced purity and consistency for laboratory research and pharmaceutical development applications.